BETABAT
Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes
| Coordinator | Lunds universitet ; THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE ; SIRION BIOTECH GMBH ; Université Libre de Bruxelles ; University of Lausanne ; Sanford-Burnham Medical Research Institute ; Autonomous University of Barcelona ; Hannover Medical School ; NOVO NORDISK INVEST 4 A/S ; Teknologian tutkimuskeskus VTT Oy ; DNA VISION SA |
| Grant period | 2011-10-01 - 2015-09-30 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2011-two-stage |
| Grant number | 277713 |
| Identifier | G:(EU-Grant)277713 |